FindTrial
Sign In

Rapid diagnosis of lung adenocarcinoma subtypes based on Terahertz molecular diagnostic technique

Rapid diagnosis of lung adenocarcinoma subtypes based on Terahertz molecular diagnostic technique

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036356
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ung adenocarcinoma

Interventions

Gold Standard:The tissue removed from the operating table is frozen into a freezer at a temperature of about 20 degrees and sliced for rapid diagnosis
Index test:Terahertz&#32
molecular&#32
recognition&#32
technique&#32
for&#32
the&#32
diagnosis&#32
of&#32
lung&#32
adenocarcinoma&#32
subtypes

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: Lung adenocarcinoma specimen

Exclusion criteria

Exclusion criteria: Other lung tumors

Design outcomes

Primary

MeasureTime frame
Lung adenocarcinoma;—

Countries

China

Contacts

Public ContactZhu JI

Changhai Hospital

drjizhu@smmu.edu.cn+86 13816739313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026